Overexpression of MiR‐335‐5p Promotes Bone Formation and Regeneration in Mice. (28th August 2017)

• Record Type: Journal Article
• Authors: Zhang, Lan; Tang, Yin; Zhu, Xiaofang; Tu, Tianchi; Sui, Lei; Han, Qianqian; Yu, Liming; Meng, Shu; Zheng, Leilei; Valverde, Paloma; Tang, Jean; Murray, Dana; Zhou, Xuedong; Drissi, Hicham; Dard, Michel M; Tu, Qisheng; Chen, Jake
• Is Part Of: Journal of bone and mineral research. Volume 32:Number 12(2017:Dec.)
• Page Start: 2466
• Page End: 2475
• Publication Date: 2017-08-28
• Subjects: MIR‐335‐5P -- TRANSGENIC MOUSE -- DKK1 -- WNT -- OSTEOGENIC DIFFERENTIATION -- BONE FORMATION; Bones -- Metabolism -- Periodicals; Mineral metabolism -- Periodicals; 612.392
• DOI: 10.1002/jbmr.3230
• Languages: English
• ISSNs: 0884-0431

Abstract

ABSTRACT: MicroRNAs (miRNAs) and the Wnt signaling pathway play critical roles in regulating bone development and homeostasis. Our previous study revealed high expression of miR‐335‐5p in osteoblasts and hypertrophic chondrocytes in mouse embryos and the ability of miR‐335‐5p to promote osteogenic differentiation by downregulating Wnt antagonist Dickkopf‐1 (DKK1). The purpose of this study was to investigate the effects of miR‐335‐5p constitutive overexpression on bone formation and regeneration in vivo. To that end, we generated a transgenic mouse line specifically overexpressing miR‐335‐5p in osteoblasts lineage by the osterix promoter and characterized its bone phenotype. Bone histomorphometry and μCT analysis revealed higher bone mass and increased parameters of bone formation in transgenic mice than in wild‐type littermates. Increased bone mass in transgenic mice bones also correlated with enhanced expression of osteogenic differentiation markers. Upon osteogenic induction, bone marrow stromal cells (BMSCs) isolated from transgenic mice displayed higher mRNA expression of osteogenic markers than wild‐type mice BMSCs cultures. Protein expression of Runx2 and Osx was also upregulated in BMSC cultures of transgenic mice upon osteogenic induction, whereas that of DKK1 was downregulated. Most important, BMSCs from transgenic mice were able to repair craniofacial bone defects as shown by μCT analysis, H&E staining, and osteocalcin (OCN) immunohistochemistry of newly formed bone in defects treated with BMSCs. Taken together, our results demonstrate constitutive overexpression of miR‐335‐5p driven by an osterix promoter in the osteoblast lineage induces osteogenic differentiation and bone formation in mice and support the potential application of miR‐335‐5p–modified BMSCs in craniofacial bone regeneration. © 2017 American Society for Bone and Mineral Research.